Clinical Trials Directory

Trials / Completed

CompletedNCT02579746

Dietary Approach to Stop Hypertension With Sodium (Na) Reduction for Chinese Canadians

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Toronto · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

The study examined the feasibility of the Dietary Approach to Stop Hypertension with Sodium (Na) Reduction for Chinese Canadian (DASHNa-CC) intervention and its potential effects on blood pressure, health-related quality of life, and health service utilization. Half of participants received usual care while the other half received the DASHNa-CC intervention.

Detailed description

Hypertension has been identified as the most important risk factor for cardiovascular diseases and accounts for a large proportion of stroke, myocardial infarction and heart failure in the Chinese population. While unhealthy diet has been identified as a modifiable risk factor for hypertension, there is a lack of culturally sensitive dietary intervention targeting Chinese Canadians. The 8-week DASHNa-CC intervention incorporated Dietary Approach to Stop Hypertension (DASH) diet, sodium reduction with the food therapy of Traditional Chinese Medicine, and included an intervention manual, two sessions of classroom instruction delivered in Mandarin, and a 20-minute telephone follow-up.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDASHNa-CCThe 8-week DASHNa-CC intervention incorporated Dietary Approach to Stop Hypertension (DASH) diet, sodium reduction with the food therapy of Traditional Chinese Medicine, and included an intervention manual, two sessions of classroom instruction delivered in Mandarin, and a 20-minute telephone follow-up.
BEHAVIORALusual careeducation booklet, encouragement of physician visit, use of public health resources if needed

Timeline

Start date
2014-08-01
Primary completion
2014-12-01
Completion
2015-08-01
First posted
2015-10-20
Last updated
2015-10-20

Source: ClinicalTrials.gov record NCT02579746. Inclusion in this directory is not an endorsement.